First Time Loading...

Atara Biotherapeutics Inc
NASDAQ:ATRA

Watchlist Manager
Atara Biotherapeutics Inc Logo
Atara Biotherapeutics Inc
NASDAQ:ATRA
Watchlist
Price: 0.52625 USD -0.69%
Updated: May 13, 2024

Atara Biotherapeutics Inc
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Atara Biotherapeutics Inc
Cash Interest Paid Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
Atara Biotherapeutics Inc
NASDAQ:ATRA
Cash Interest Paid
$447k
CAGR 3-Years
95%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash Interest Paid
$2.5B
CAGR 3-Years
-2%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Cash Interest Paid
$891m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash Interest Paid
$43.1m
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
15%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Atara Biotherapeutics Inc's Cash Interest Paid?
Cash Interest Paid
447k USD

Based on the financial report for Dec 31, 2023, Atara Biotherapeutics Inc's Cash Interest Paid amounts to 447k USD.

What is Atara Biotherapeutics Inc's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
13%

Over the last year, the Cash Interest Paid growth was 31%. The average annual Cash Interest Paid growth rates for Atara Biotherapeutics Inc have been 95% over the past three years , 13% over the past five years .